Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gentamicine-EDTA, a New Anti-biofilm Strategy for the Conservative Treatment of Catheter-related Infections

NCT04789928 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.

NCT NCT04789928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04789928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gentamicine-EDTA, a New Anti-biofilm Strategy for the Conservative Treatment of Catheter-related Infections
Lead sponsor
Institut Pasteur
Phase
Phase 1
Overall status
Completed
Start date
January 5, 2021
Completion date
March 1, 2024
Enrollment
8 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

patients with uncomplicated long-term central venous catheter-related biofilm-related infection